GlassScriptPhysician profile
Kai Mcgreevy
NPI 1922208610
$15,435.55
in general payments reported to CMS, 2019-2025
69 companies · $4,504 in 2025
The $4,504 reported for 2025 was more than what 84% of Neurology (Psychiatry & Neurology) providers received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,373 · 2020: $349 · 2021: $2,334 · 2022: $2,570 · 2023: $1,167 · 2024: $3,139 · 2025: $4,504.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,984 · Travel and Lodging: $2,636 · Education: $190.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,984.06 |
| Travel and Lodging | $2,636.15 |
| Education | $189.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $2,613.94 | 2019-2025 | General - Pain Management, Wavewriter Alpha Prime 16, Bionic Navigator |
| Abbott Laboratories | $1,849.94 | 2019-2025 | Proclaim, Durata, Eterna |
| Spinal Simplicity, LLC | $1,117.90 | 2024-2025 | Ha Minuteman G3-R, Liberty Si |
| Abbvie INC. | $1,010.08 | 2021-2025 | |
| Curonix LLC | $936.57 | 2023-2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Neuronetics, INC. | $805.98 | 2019 | |
| Painteq LLC | $539.90 | 2021-2024 | Painteq |
| Lilly USA, LLC | $487.98 | 2021-2025 | Amyvid, Kisunla, Emgality |
| Eisai INC. | $447.92 | 2022-2025 | |
| Bard Peripheral Vascular, INC. | $368.69 | 2021-2022 | |
| Trice Medical, INC. | $342.70 | 2022 | |
| Pfizer INC. | $293.17 | 2023-2025 | |
| Relievant Medsystems, INC. | $273.61 | 2021 | |
| Kyowa Kirin, INC. | $264.06 | 2023-2024 | Nourianz |
| Lundbeck LLC | $240.38 | 2020-2025 | Vyepti, Rexulti |
Show all 69 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kai Mcgreevy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.